SLC31A1 and neoplasm: In tumor cell-enriched region, higher expression of SLC31A1 (P = 0.001) was associated with worse prognosis of NPC patients, while the opposite was true for LIPT2 (P = 0.012) and ATP7A (P = 0.011) (Figure 2C).